Teva Pharmaceutical reported $3.6B in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aspen Pharmacare APN:SJ ZAR 19.23B 156M
Cipla CIPLA:IN INR 58.29B 4.53B
Dr.Reddys Laboratories DRRD:IN INR 63.32B 10.99B
Guangzhou Baiy 600332:CH CNY 17.59B 903.52M
Jiangsu Hengrui Me. 600276:CH CNY 5.72B 967.76M
Kalbe Farma Tbk Pt KLBF:IJ IDR 7.31T 448.3B
Richter Gedeon RICHT:HB HUF 217.81B 24.88B
Sh Fosun Pharma 600196:CH CNY 10.27B 688.1M
Sun Pharmaceuticals SUNP:IN INR 109.52B 1.91B
Teva Pharmaceutical TEVA:IT USD 3.6B 191M